Annals of Hepato-Biliary-Pancreatic Surgery

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2508-5859   pISSN 2508-5778

Table. 2.

Table. 2.

Surgical or percutaneous approaches, and postopera-tive courses

p value
Surgical approach (%)
Resection (%) 182 (86.3)
Non-PSH 65
Right/Extended right hepatectomy 53
Left/Extended left hepatectomy 12
PSH 117
Bi-segmentectomy 31
Segmentectomy 74
Atypical resection 12
RFA (%) 13 (6.2)
Percutaneous approach (MWA) (%) 16 (7.5)
Combined primary tumor resection (%) 52 (61.9a)
Colon 39
Rectum 13
Morbidity (%) 49 (23.2) ns
Resection 48
RFA 0
Percutaneous MWA (Table 1) 1
30-day mortality (%) 0 ns
Length of hospital stay (days) (±SD) 10 (±5) <.01
Resection 11
RFA 2
Percutaneous MWA 8
Readmission (%) 2 (0.9) ns
Resection 2
RFA 0
Percutaneous MWA 0

aAccording to the number of synchronous diseases

SD, standard deviation; PSH, parenchyma-sparing hepatectomy; RFA, radiofrequency ablation; MWA, microwave ablation

Ann Hepatobiliary Pancreat Surg 2021;25:198-205 https://doi.org/10.14701/ahbps.2021.25.2.198
© 2021 Ann Hepatobiliary Pancreat Surg